NVO
Novo Nordisk A/S
Stock
$37.32−0.08 (−0.21%)Close Oct 2, 2026
- Revenue, 2025
- DKK 309.1B
- YoY, 2025
- +6.4%
- 5-year CAGR
- +19.5%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | DKK 309.1B | +6.4% |
| 2024 | DKK 290.4B | +25.0% |
| 2023 | DKK 232.3B | +31.3% |
| 2022 | DKK 177.0B | +25.7% |
| 2021 | DKK 140.8B | +10.9% |
| 2020 | DKK 126.9B | +4.0% |
| 2019 | DKK 122.0B | — |